Dergiler / Turkish Journal of Biology / 2017 / Cilt: 41 - Sayı: 6

Improved insulin-secreting properties of pancreatic islet mesenchymal stem cells by constitutive expression of Pax4 and MafA

Sayfa
979–991
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, support of this differentiation process using additional chemical induction may suffice to overcomecontrol by endogenous regulatory pathways.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:For long-term treatment of diabetes type 1, transplantation of insulin-producing beta cells may be a promising method, but thelimited number of islets for transplantation requires the development of different approaches.
📊
Temel Bulgular & Veri:In this study, we aimed to generate beta- like insulin-producing cells.
💡
Sonuç & Katkı:However, support of this differentiation process using additional chemical induction may suffice to overcomecontrol by endogenous regulatory pathways.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

For long-term treatment of diabetes type 1, transplantation of insulin-producing beta cells may be a promising method, but thelimited number of islets for transplantation requires the development of different approaches. In this study, we aimed to generate beta- like insulin-producing cells. For this purpose, MafA, Pax4, and Ngn3 genes were transferred into pancreatic islet-derived mesenchymalstem cells, and the effect of their ectopic expressions on differentiation efficiency was examined. Stemness properties of pancreaticislet stem cells were characterized. The 3 genes were transfected by electroporation and expressed constitutively. The transfected cellswere further stimulated to differentiate by using chemical induction. Pax4 expression had significant effects on differentiation intoinsulin-producing cells. Although it caused morphological alterations in cells, similar to epithelial cells, the insulin secretion levelsremained lower than those of the cell line cotransfected with MafA and Pax4. Cotransfection of the 3 transcription factors did notfurther improve the beta-like cell generation. MafA and Pax4 ectopic expression resulted in improved differentiation efficiency intoinsulin-secreting cells. However, support of this differentiation process using additional chemical induction may suffice to overcomecontrol by endogenous regulatory pathways.

🔖

Bu Makaleye Atıf Yap

AÇIKSARI, A., KARAÖZ, E., DURUKSU, G. (2022). Improved insulin-secreting properties of pancreatic islet mesenchymal stem cells by constitutive expression of Pax4 and MafA. Turkish Journal of Biology, Cilt: 41 - Sayı: 6, 979–991. https://ajindex.com/articles/600280

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Akinci E, Banga A, Greder LV, Dutton JR, Slack JM (2012). Reprogramming of pancreatic exocrine cells towards a beta (beta) cell character using Pdx1, Ngn3, and MafA. Biochem J 442: 539-550.
  2. Akinci E, Banga A, Tungatt K, Segal J, Eberhard D, Dutton JR, Slack JM (2013). Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3, and MafA. PLoS One 8: e82424. Baeyens L, Bonné S, German MS, Ravassard P, Heimberg H, Bouwens L (2006). Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway. Cell Death Differ 13: 1892-1899.
  3. Bernardo AS, Hay CW, Docherty K (2008). Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol Cell Endocrinol 294: 1-9.
  4. Courtney M, Pfeifer A, Al-Hasani K, Gjernes E, Vieira A, Ben- Othman N, Collombat P (2011). In vivo conversion of adult α-cells into β-like cells: a new research avenue in the context of type 1 diabetes. Diabetes Obes Metab 13: 47-52.
  5. Czubak P, Bojarska-Junak A, Tabarkiewicz J, Putowski L (2014). A modified method of insulin producing cells’ generation from bone marrow-derived mesenchymal stem cells. J Diabetes Res 2014: 628591. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006). Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
  6. Gabr MM, Zakaria MM, Refaie AF, Ismail AM, Abou-El-Mahasen MA, Ashamallah SA, Khater SM, El-Halawani SM, Ibrahim RY, Uin GS et al. (2013). Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin- induced diabetes in nude mice. Cell Transplant 22: 133-145.
  7. Guo QS, Zhu MY, Wang L, Fan XJ, Lu YH, Wang ZW, Zhu SJ, Wang Y, Huang Y (2012). Combined transfection of the three transcriptional factors PDX-1, NeuroD1, and MafA causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells. Exp Diabetes Res 2012: 672013.
  8. Hashemian SJ, Kouhnavard M, Nasli-Esfahani E (2015). Mesenchymal stem cells: rising concerns over their application in treatment of type one diabetes mellitus. J Diabetes Res 2015: 675103. He D, Wang J, Gao Y, Zhang Y (2011). Differentiation of PDX1 gene- modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro. Int J Mol Med 28: 1019-1024.
  9. Johansson KA, Dursun U, Jordan N, Gu G, Beermann F, Gradwohl G, Gr